Golimumab Biosimilar – Anti-TNFA/TNF alpha mAb – Research Grade




Product type


Expression system

Description of Golimumab Biosimilar - Anti-TNFA/TNF alpha mAb - Research Grade

General information on Anti-TNFA/TNF alpha(Homo sapiens) (Golimumab) Monoclonal Antibody

Golimumab is a human IgG1? monoclonal antibody, developped from genetically engineered mice immunized with human TNF?. Golimumab binds to and inhibits soluble and transmembrane human TNF?. Elevated TNF? is related to chronic inflammation. Therefore, golimumab can be used in adults,for the treatment of active rheumatoid arthritis (RA), active psoriatic arthritis ( PsA), active ankylosing spondylitis (AS), ulcerative colitis (UC). In the United States and Canada, golimumab is sold under the Simponi® brand. The FDA label includes a black box that warns of serious infections and malignant tumors.

Product nameGolimumab Biosimilar - Anti-TNFA/TNF alpha mAb - Research Grade
SourceCAS 476181-74-5
SpeciesHomo sapiens
Expression systemMammalian cells
Molecular weight147kDa
BufferPBS buffer PH7.5
Delivery conditionDry Ice
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
Aliases /SynonymsCNTO 148
Related ProductsHuman TNFa Recombinant Protein
NoteFor research use only. Not suitable for clinical or therapeutic use.
ClonalityMonoclonal Antibody
SourceCAS 476181-74-5


There are no reviews yet.

Be the first to review “Golimumab Biosimilar – Anti-TNFA/TNF alpha mAb – Research Grade”

Your email address will not be published. Required fields are marked *


Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us to order

+33 (0)3 90 20 54 70

Write us